CD274 and neoplasm: To better understand how ICIs work, one should understand that when the link is made between the PD-1 receptor present on cytotoxic T lymphocytes and the PD-L1 ligand located on tumor cells, it creates a shield, making the tumor cell invisible to T lymphocytes.